期刊文献+

酪蛋白激酶2结合并磷酸化ataxin-3(英文) 被引量:2

Casein kinase 2 interacts with and phosphorylates ataxin-3
下载PDF
导出
摘要 目的马查多-约瑟夫病/脊髓小脑共济失调3型,是由MJD1基因产物ataxin-3的C-末端的多聚谷氨酰胺发生重复扩展突变而引起的一种常染色体显性遗传的神经退行性疾病,目前它的发病机制还不清楚。很多研究表明磷酸化修饰作用在很多神经退行性疾病的发病过程中起到重要作用,然而已知可以磷酸化ataxin-3的激酶仍然很少。本研究的目的是探讨酪蛋白激酶2(Casein kinase 2,CK2)对于ataxin-3的磷酸化作用。方法通过GST pull-down和免疫共沉淀技术鉴定ataxin-3和CK2的相互作用。通过体外磷酸化技术检测CK2对ataxin-3的磷酸化。结果(1)正常和扩展突变型ataxin-3在体外与CK2α、β亚单位均发生相互作用;(2)在293细胞中正常和扩展突变型ataxin-3只和CK2β亚单位相互作用,而与α亚单位没有结合;(3)正常和扩展突变型ataxin-3都可以被CK2磷酸化。结论Ataxin-3是蛋白激酶CK2的底物。 Objective Machado-Joseph disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant neurodegenerative disorder caused by an expansion of polyglutamine tract near the C-terminus of the MJD1 gene product, ataxin-3. The precise mechanism of the MJD/SCA3 pathogenesis remains unclear. A growing body of evidence demonstrates that phosphorylation plays an important role in the pathogenesis of many neurodegenerative diseases. However, few kinases are known to phosphorylate ataxin-3. The present study is to explore whether ataxin-3 is a substrate of casein kinase 2 (CK2). Methods The interaction between ataxin-3 and CK2 was identified by glutathione S-transferase (GST) pull-down assay and co-immunoprecipition assay. The phosphorylation of ataxin-3 by CK2 was measured by in vitro phosphorylation assays. Results (1) Both wild type and expanded ataxin-3 interacted with CK2α and CK2β in vitro. (2) In 293 cells, both wild type and expanded ataxin-3 interacted with CK2β, but not CK2α. (3) CK2 phosphorylated wild type and expanded ataxin-3. Conclusion Ataxin-3 is a substrate of protein kinase CK2.
出处 《Neuroscience Bulletin》 SCIE CAS CSCD 2008年第5期271-277,共7页 神经科学通报(英文版)
基金 the National Natural Sciences Foundation of China (No. 30770664) a grant from Educational Committee of Anhui Province, China (No. ZD2008008-2).
关键词 马查多-约瑟夫病/脊髓小脑共济失调3型 ATAXIN-3 酪蛋白激酶2 磷酸化 Machado-Joseph disease/spinocerebellar ataxia type 3 ataxin-3 casein kinase 2 phosphorylation
  • 相关文献

参考文献1

二级参考文献21

  • 1Muchowski PJ, Schaffar G, Sittler A, et al. HSP70 and HSP40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci USA, 2000, 97: 7841-7846.
  • 2Takata K, Kitamura Y, Tsuehiya D, et al. Heat shock protein-90-induced mieroglial clearance of exogenous amyloid-betal-42 in rat hippocampus in vivo. Neurosci Lett, 2003, 344: 87-90.
  • 3McLean PJ, Kawamata H, Shariff S, et al. TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation. J Neurochem, 2002, 83: 846-854.
  • 4Latchman DS. Protective effect of heat shock proteins in the nervous system. Current Neurovascular Res, 2004, 1: 21-27.
  • 5Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neurodegenerative disease. Science, 2002, 296: 1991-1995.
  • 6Yang W, Dunlap JR, Andrews RB, et al. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells.Hum Mol Genet, 2002, 11 : 2905-2917.
  • 7Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science, 2003, 300: 486-489.
  • 8Stefani M, Dobson CM. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med, 2003, 81 : 678-699.
  • 9Berke SJ, Paulson HL. Protein aggregation and the ubiquitin proteasome pathway: gaining the upper hand on neurodegeneration. Curr Opin Genet Dev, 2003, 13 : 253-261.
  • 10Presenilin-1, nicastrin, amyloid precursor protein, and gammasecretase activity are co-localized in the lysosomal membrane. J Biol Chem, 2003, 278: 26687-26694.

同被引文献13

  • 1李大江,刘焱斌,刘凯.生物信息学在未来感染病学教学中的地位和作用[J].华西医学,2006,21(3):474-476. 被引量:6
  • 2ROY AK,TYAGI RK, SONG CS,et al. Androgen receptor:structural domains and functional dynamics after ligand-receptorinteraction[JJ. Ann N Y Acad Sci,2009,949(4) :44-57.
  • 3LIAO X.TANG S, THRASHER JB, et al. Small-interferingRNA-induced androgen receptor silencing leads to apoptotic celldeath in prostate cancer [J], Mol Cancer Ther, 2008 *4 ( 12):505-515.
  • 4GOT2 C, BACHMANN C, MONTENARH M. Inhibition ofprotein kinase CK2 leads to a modulation of androgen receptordependent transcription in prostate cancer cells [J]. Prostate,2009,67(6): 125-134.
  • 5SLATON JW, UNGER GM, SLOPER DT, et al. Induction ofapoptosis by antisense CK2 in human prostate cancer xenograftmodel[J]. Mol Cancer Res,2010,2(9) : 712-721.
  • 6WANG G,AHMAD KA,UNGER G,et al. CK2 signaling in an-drogen-dependent and -independent prostate cancer [J]. J CellBiochem,2009,99(1): 382-391.
  • 7GUO C, YU S,DAVIS AT, et al. Nuclear matrix targeting ofthe protein kinase CK2 signal as a common downstream responseto androgen or growth factor stimulation of prostate cancer cells[J]. Cancer Res,2008,59(7) : 1146-1151.
  • 8PAGANO MA,BAIN J, KAZIMIERCZUK Z,et al. The selec-tivity of inhibitors of protein kinase CK2; an update[J], Bio-chem J, 2008; 415(3):353-365.
  • 9BATTISTUTTA R.SARNO S,DEMOUNER E,et al. The re-placement of ATP by the competitive inhibitor emodin inducesconformational modifications in the catalytic site of protein ki-nase CK2[J]. J Biol Chem,2010,275(ll): 29618-29622.
  • 10叶定伟,朱一平.激素抵抗性前列腺癌的治疗选择[J].现代泌尿外科杂志,2011,16(1):6-9. 被引量:17

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部